Glenn Arendts

Dr. Glenn Arendts

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2010 in Age and Ageing
Verified
Journal Article
Open access
PDF file
GAGlenn Arendts
Glenn Arendts
KHKirsten Howard
Kirsten Howard
Background: emergency care for older people living in residential aged care facilities (RACF) is a complex area of health policy. The epidemiology of patient transfer between RACF and hospital emergency departments (ED), clinical outcomes and costs associated with transfer and efficacy of programs aiming to reduce transfer are not well known. Design: systematic review based on a comprehensive literature search in three electronic databases and published article reference lists. Results: the incidence of transfer from RACF to ED is >30 transfers/100 RACF beds/year in most studies. The casemix from RACF is varied and reflects that of the broad elderly population, with some risk difference. At least 40% of transfers are not admitted to hospital. There is insufficient data to fully address our other questions; however, hospitalisations from RACF can be reduced through advanced care planning, use of management guidelines for acute illnesses and improved primary care. Conclusions: residents of RACF have a high annual risk of transfer to ED. The clinical benefit and cost effectiveness of ED care, and alternate programs to reduce ED transfer, cannot be confidently compared from published work. Further research is required to accurately describe these and to determine their comparative worth.

31 October 2018 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
SMStephen Macdonald
Stephen Macdonald
GKGerben Keijzers
Gerben Keijzers
DTDavid McD Taylor
David McD Taylor
FKFrances Kinnear
Frances Kinnear
GAGlenn Arendts
Glenn Arendts
FIfor the REFRESH trial investigators
for the REFRESH trial investigators

6 November 2014 in Academic Emergency Medicine
Verified
Journal Article
Closed access
PDF file
SMStephen Macdonald
Stephen Macdonald
GAGlenn Arendts
Glenn Arendts
DFDaniel M Fatovich
Daniel M Fatovich
SBSimon G A Brown
Simon G A Brown

1 February 2020 in Annals of Emergency Medicine
Verified
Journal Article
Closed access
LSLauren T. Southerland
Lauren T. Southerland
ALAlexander X. Lo
Alexander X. Lo
KBKevin Biese
Kevin Biese
GAGlenn Arendts
Glenn Arendts
JBJay Banerjee
Jay Banerjee
CCChristopher R. Carpenter
Christopher R. Carpenter

24 October 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SMStephen Macdonald
Stephen Macdonald
SSShelley F Stone
Shelley F Stone
CNClaire L Neil
Claire L Neil
PEPauline E Van Eeden
Pauline E Van Eeden
DFDaniel M Fatovich
Daniel M Fatovich
SBSimon G A Brown
Simon G A Brown
To identify biomarkers which distinguish severe sepsis/septic shock from uncomplicated sepsis in the Emergency Department (ED). Patients with sepsis underwent serial blood sampling, including arrival in the ED and up to three subsequent time points over the first 24 hours. Messenger RNA (mRNA) levels of 13 genes representing arms of the innate immune response, organ dysfunction or shock were measured in peripheral blood leucocytes using quantitative PCR, and compared with healthy controls. Serum protein concentrations of targets differentially expressed between uncomplicated sepsis and severe sepsis/septic shock were then measured at each time point and compared between the two patient groups. Of 27 participants (median age 66 years, (IQR 35, 78)), 10 had uncomplicated sepsis and 17 had sepsis with organ failure (14 septic shock; 3 had other sepsis-related organ failures). At the time of first sample collection in the ED, gene expression of Interleukin (IL)-10 and Neutrophil Gelatinase Associated Lipocalin (NGAL) were significantly higher in severe sepsis than uncomplicated sepsis. Expression did not significantly change over time for any target gene. Serum concentrations of IL-6, IL-8, IL-10, NGAL and Resistin were significantly higher in severe sepsis than uncomplicated sepsis at the time of first sample collection in the ED, but only IL-8, NGAL and Resistin were consistently higher in severe sepsis compared to uncomplicated sepsis at all time points up to 24 h after presentation. These mediators, produced by both damaged tissues and circulating leukocytes, may have important roles in the development of severe sepsis. Further work will determine whether they have any value, in addition to clinical risk parameters, for the early identification of patients that will subsequently deteriorate and/or have a higher risk of death.